Services Institute of Medical Sciences
Lahore, Punjab Province, 54000, Pakistan
NCT Number: NCT07395388
This randomized controlled trial aims to evaluate the efficacy of intraoperative methylene blue (MB) spray in improving the identification and preservation of the recurrent laryngeal nerve (RLN) and parathyroid glands (PGs) during thyroidectomy. The study compares outcomes between patients receiving topical MB spray and those undergoing conventional visual dissection alone. Primary outcomes include the incidence of RLN injury and postoperative serum calcium levels.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Lahore, Punjab Province, 54000, Pakistan
Thyroidectomy is associated with risks of iatrogenic injury to the RLN and PGs, leading to vocal cord paralysis and hypocalcemia. This study investigates whether topical application of methylene blue spray can enhance intraoperative visualization and preservation of these structures. A total of 136 patients with benign multinodular goiter were randomized into two groups: an experimental group receiving MB spray and a control group receiving conventional dissection. RLN injury was assessed via postoperative laryngoscopy, and serum calcium levels were measured at 72 hours postoperatively.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intraoperative topical spray of 0.5 mL methylene blue applied to the thyroid lobe and surrounding tissue after mobilization.
Conventional visual identification and dissection without dye.
Time frame: 2 hours (at extubation)
Incidence of recurrent laryngeal nerve injury (assessed by indirect laryngoscopy
Time frame: At 72 hours
Postoperative serum calcium levels
Services Hospital, Lahore
Other Gov
Intraoperative Methylene Blue Spray for the Identification and Preservation of Vital Structures in Thyroidectomy: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05043584
Autofluorescence, Calcium Metabolism Disorders
Esbjerg, Denmark
View Trial DetailsNCT07617584
Calcium Metabolism Disorders, Endocrine Gland Neoplasms
Skopje, North Macedonia
View Trial DetailsNCT00743782
Autoimmune Diseases, Autoimmune Polyendocrine Syndrome Type 1
Bethesda, Maryland, United States
View Trial DetailsNCT01199614
Calcium Metabolism Disorders, Endocrine System Diseases
New York, United States
View Trial Details